Pliant Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Pliant Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Pliant Therapeutics Inc
Rating: 1.27825
Author: Trendlyne DVM scores

about

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small m...

1.52 0.06 (4.11%)

90.56% Fall from 52W High

577.3K

XNAS Volume

XNAS 30 Jul, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for Pliant Therapeutics Inc is on 07 Aug 2025 for the purpose of Pliant Therapeutics Inc Second Quarter Earnings Results for 2025 See details